Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3

Brain Research

Volumn 1188, Issue 1, 2008, Pages 254-262

  Koh, Seong Ho ^a   Noh, Min Young ^a   Kim, Seung Hyun ^a  

^a Hanyang University   (South Korea)

Author keywords

Alzheimer's dementia; Amyloid beta; Glycogen synthase kinase 3; Neurotoxicity

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; AMYLOID BETA PROTEIN[1-42]; CASPASE 3; CYTOCHROME C; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; HEAT SHOCK TRANSCRIPTION FACTOR 1; TAU PROTEIN; TRYPAN BLUE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; NERVE CELL; NEUROTOXICITY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; CYTOCHROMES C; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; INDICATORS AND REAGENTS; NERVE DEGENERATION; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TAU PROTEINS; TETRAZOLIUM SALTS; TRANSCRIPTION FACTORS;

EID: 37349109154     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.10.064     Document Type: Article

References (34)

1. Bhat R., Xue Y., Berg S., Hellberg S., Ormo M., Nilsson Y., Radesater A.C., Jerning E., Markgren P.O., Borgegard T., Nylof M., Gimenez-Cassina A., Hernandez F., Lucas J.J., Diaz-Nido J., and Avila J. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J. Biol. Chem. 278 (2003) 45937-45945
2. Bijur G.N., and Jope R.S. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSTF-1 activity. J. Neurochem. 75 (2000) 2401-2408
3. Bijur G.N., and Jope R.S. Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J. Biol. Chem. 276 (2001) 37436-37442
4. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloidbeta peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
5. Embi N., Rylatt D.B., and Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107 (1980) 519-527
6. Filomeni G., Aquilano K., Rotilio G., and Ciriolo M.R. Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Res. 63 (2003) 5940-5949
7. Ghribi O., Herman M.M., and Savory J. Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation. J. Neurosci. Res. 71 (2003) 853-862
8. Gould T.D., Einat H., Bhat R., and Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int. J. Neuropsychopharmacol. 7 (2004) 387-390
9. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
10. Jellinger K.A. Alzheimer disease and cerebrovascular pathology: an update. J. Neural Trans. 109 (2002) 813-836
11. Jellinger K.A., and Bancher C. Neuropathology of Alzheimer's disease: a critical update. J. Neural Transm., Suppl. 54 (1998) 77-95
12. Jiang Q., Gu Z., Zhang G., and Jin G. Diphosphorylation and involvement of extracellular signal-regulated kinases (ERK1/2) in glutamate-induced apoptotic-like death in cultured rat cortical neurons. Brain Res. 857 (2000) 71-77
13. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
14. Kirschenbaum F., Hsu S.C., Cordell B., and McCarthy J.V. Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels. J. Biol. Chem. 276 (2001) 30701-30707
15. Koh S.H., Kim S.H., Kwon H., Park Y., Kim K.S., Song C.W., Kim J., Kim M.H., Yu H.J., Henkel J.S., and Jung H.K. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. Brain Res. Mol. Brain Res. 118 (2003) 72-81
16. Koh S.H., Kim S.H., Kwon H., Kim J.G., Kim J.H., Yang K.H., Kim J., Kim S.U., Yu H.J., Do B.R., Kim K.S., and Jung H.K. Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cells. Neurotoxicology 25 (2004) 793-802
17. 2 induced death of neuronal-differentiated PC12 cells. J. Korean Neurol. Assoc. 22 (2004) 375-381
18. Koh S.H., Lee Y.B., Kim K.S., Kim H.J., Kim M., Lee Y.J., Kim J., Lee K.W., and Kim S.H. Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene. Eur. J. Neurosci. 22 (2005) 301-309
19. Lee K.Y., Koh S.H., Noh M.Y., Park K.W., Lee Y.J., and Kim S.H. Glycogen synthase kinase-3β activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells. Brain Res. 1129 (2007) 89-99
20. Martinez A., Castro A., Dorronsoro I., and Alonso M. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. Med. Res. Rev. 22 (2002) 373-384
21. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., and Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
22. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., and Duff K. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6990-6995
23. Pap M., and Cooper G.M. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway. Mol. Cell. Biol. 22 (2002) 578-586
24. Robinson S.R., and Bishop G.M. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol. Aging 23 (2002) 1051-1072
25. Rockenstein E., Torrance M., Adame A., Mante M., Bar-on P., Rose J.B., Crews L., and Masliah E. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J. Neurosci. 27 (2007) 1981-1991
26. Ryves W.J., Fryer L., Dale T., and Harwood A.J. An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts. Anal. Biochem. 264 (1998) 124-127
27. Tammariello S.P., Quinn M.T., and Estus S. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J. Neurosci. 20 (2000) 1-5
28. Takadera T., and Ohyashiki T. Glycogen synthase kinase-3 inhibitors prevent caspase-dependent apoptosis induced by ethanol in cultured rat cortical neurons. Eur. J. Pharmacol. 499 (2004) 239-245
29. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., and Imahori K. Exposure of rat hippocampal neurons to amyloid h peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3h. Neurosci. Lett. 203 (1996) 33-36
30. Trojanowski J.Q., and Lee V.M. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. N. Y. Acad. Sci. 924 (2000) 62-67
31. Vasdev N., Natesan S., Galineau L., Garcia A., Stableford W.T., McCormick P., Seeman P., Houle S., and Wilson A.A. Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N′-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies. Bioorg. Med. Chem. Lett. 15 (2005) 5270-5273
32. Verdile G., Fuller S., Atwood C.S., Laws S.M., Gandy S.E., and Martins R.N. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?. Pharmacol. Res. 50 (2004) 397-409
33. Watcharasit P., Bijur G.N., Song L., Zhu J., Chen X., and Jope R.S. Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. J. Biol. Chem. 278 (2003) 48872-48879
34. Yatin S.M., Aksenova M., Aksenov M., Markesbery W.R., Aulick T., and Butterfield D.A. Temporal relations among beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. J. Mol. Neurosci. 11 (1998) 183-197